APPLICATION
ANDA077932
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-19
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
MELOXICAMPrescription
MELOXICAM 7.5MG · TABLET · ORAL
MELOXICAMPrescription
MELOXICAM 15MG · TABLET · ORAL
Approval history
2024-11-21Labeling · Supplement 11 · standardAP
2022-01-07Labeling · Supplement 10 · standardAP
2016-09-25Labeling · Supplement 9 · standardAP
2016-09-25Labeling · Supplement 7 · standardAP
2016-09-25Labeling · Supplement 8 · standardAP
2013-06-10Labeling · Supplement 5AP
2013-06-10Labeling · Supplement 6 · standardAP
2010-06-15Labeling · Supplement 2AP
2007-08-14Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.